- Report
- May 2026
- 135 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- January 2026
- 198 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- October 2025
- 89 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- August 2026
- 196 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- August 2026
- 510 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- January 2026
- 191 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2026
- 197 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 180 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- January 2026
- 185 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- July 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- August 2026
- 373 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- August 2026
- 260 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- January 2026
- 185 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- November 2025
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- June 2026
- 110 Pages
United States
From €4266EUR$4,750USD£3,644GBP
- Report
- May 2023
- 110 Pages
Global
From €5344EUR$5,950USD£4,565GBP

The Nerve Repair market within the context of Genomics is focused on the development of treatments and therapies that can help to repair damaged nerves. This includes the use of gene therapy, stem cell therapy, and other regenerative medicine approaches. Genomics has enabled researchers to better understand the genetic basis of nerve damage and to develop treatments that can target specific genetic pathways. In addition, genomics has enabled the development of personalized treatments that can be tailored to the individual patient.
Companies in the Nerve Repair market include AxoGen, Inc., BioTime, Inc., BrainStorm Cell Therapeutics, Inc., and Neuralstem, Inc. Show Less Read more